LEWIS JOEL sold 9.2% of their position (84K shares) of GALECTIN THERAPEUTICS INC on the open market
Open‑market sale worth $321.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/6/2026ACC: 0001133416-26-000008
-84K
Net shares
Net seller
$321.1K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
84K acquired · 168K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+84K
Price / share
—
Trade value
—
% of position
10.1%
1/2/2026
832.59K→916.59K
Common Stock
Direct
Shares
−18.57K
Price / share
$4.20
Trade value
$77.94K
% of position
2.0%
1/2/2026
916.59K→898.02K
Common Stock
Direct
Shares
−27.73K
Price / share
$3.91
Trade value
$108.34K
% of position
3.1%
1/5/2026
898.02K→870.29K
Common Stock
Direct
Shares
−37.70K
Price / share
$3.58
Trade value
$134.85K
% of position
4.3%
1/6/2026
870.29K→832.59K
Total
Net shares
+0.00
Net value
-$321.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | M · Option Exercise | +84K | — | — | 10.1% | 832.59K | 916.59K |
| Common Stock Direct | 1/2/2026 | S · Sale | −18.57K | $4.20 | $77.94K | 2.0% | 916.59K | 898.02K |
| Common Stock Direct | 1/5/2026 | S · Sale | −27.73K | $3.91 | $108.34K | 3.1% | 898.02K | 870.29K |
| Common Stock Direct | 1/6/2026 | S · Sale | −37.70K | $3.58 | $134.85K | 4.3% | 870.29K | 832.59K |
| Total | +0.00 | -$321.13K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
84K shares
Shares
−84K
Strike price
0
Held after
0.00
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock84K shares | 1/2/2026 | M · Option Exercise | −84K | 0 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2K
Total
2K indirect2K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Indirect |
| Total | 2K | 2K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported